An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

Abstract excerpt

BACKGROUND: Estrogen receptor (ER)-negative breast cancer specimens are predominantly of high grade, have frequent p53 mutations, and are broadly divided into HER2-positive and basal subtypes. Although ER-negative disease has overall worse prognosis than does ER-positive breast cancer, not all ER-negative breast cancer patients have poor clinical outcome. Reliable identification of ER-negative tumors that have a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Breast Cancer Treatment Studies
• Share to Cancer Immunotherapy and Biomarkers
• Share to Ferroptosis and cancer prognosis